3 European Stocks Estimated To Be Trading Below Intrinsic Value In January 2026

Simply Wall St · 6d ago

As the European markets continue to thrive, with the STOXX Europe 600 Index reaching new highs and closing 2025 with impressive gains, investors are increasingly looking for opportunities within this robust economic environment. In such a context, identifying stocks that may be trading below their intrinsic value can provide potential avenues for growth, particularly when these stocks are supported by strong fundamentals and positive market conditions.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Name Current Price Fair Value (Est) Discount (Est)
Truecaller (OM:TRUE B) SEK18.50 SEK36.62 49.5%
Streamwide (ENXTPA:ALSTW) €73.00 €142.93 48.9%
Recupero Etico Sostenibile (BIT:RES) €6.56 €12.99 49.5%
NEUCA (WSE:NEU) PLN835.00 PLN1647.82 49.3%
LINK Mobility Group Holding (OB:LINK) NOK33.30 NOK66.22 49.7%
Jæren Sparebank (OB:JAREN) NOK384.00 NOK751.23 48.9%
Gesco (XTRA:GSC1) €14.30 €27.86 48.7%
Fodelia Oyj (HLSE:FODELIA) €5.44 €10.72 49.3%
Benefit Systems (WSE:BFT) PLN3590.00 PLN7095.77 49.4%
Allcore (BIT:CORE) €1.36 €2.66 48.9%

Click here to see the full list of 197 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Here we highlight a subset of our preferred stocks from the screener.

Digi Communications (BVB:DIGI)

Overview: Digi Communications N.V. offers telecommunication services including cable TV, internet, and mobile telephony in Romania, Spain, and Italy with a market cap of RON10.51 billion.

Operations: The company's revenue primarily comes from wireless communications services, totaling €2.21 billion.

Estimated Discount To Fair Value: 31.8%

Digi Communications is trading at RON110.2, significantly below its estimated fair value of RON161.47, indicating potential undervaluation based on cash flows. Despite a low return on equity forecast of 6% in three years and declining profit margins from 18.4% to 2%, earnings are expected to grow substantially by 25% annually, outpacing the regional market's growth rate. Recent earnings reports show increased sales but a sharp drop in net income year-over-year.

BVB:DIGI Discounted Cash Flow as at Jan 2026
BVB:DIGI Discounted Cash Flow as at Jan 2026

SPIE (ENXTPA:SPIE)

Overview: SPIE SA is a company that offers multi-technical services in energy and communications across France, Germany, the Netherlands, and internationally with a market cap of €8.27 billion.

Operations: The company generates revenue from various segments, including €3.46 billion from Germany, €775.20 million from Central Europe, €2.09 billion from North-Western Europe, and €483.40 million from Global Services Energy.

Estimated Discount To Fair Value: 41.2%

SPIE, trading at €49.2, is significantly undervalued compared to its estimated fair value of €83.65, highlighting potential based on cash flows. While the company faces high debt levels and slower revenue growth than the French market, earnings are projected to grow at a robust 20.1% annually over the next three years. The recent European framework agreement with Tesla for battery energy storage systems may further enhance SPIE's strategic positioning in energy transition projects across Europe.

ENXTPA:SPIE Discounted Cash Flow as at Jan 2026
ENXTPA:SPIE Discounted Cash Flow as at Jan 2026

AlzChem Group (XTRA:ACT)

Overview: AlzChem Group AG, with a market cap of €1.59 billion, develops, produces, and markets a variety of chemical specialties across Germany, the European Union, the rest of Europe, Asia, the NAFTA region, and internationally.

Operations: The company's revenue is primarily derived from its Specialty Chemicals segment, which accounts for €370.59 million, and its Basics & Intermediates segment, contributing €163.48 million.

Estimated Discount To Fair Value: 32.7%

AlzChem Group, trading at €157.4, is highly undervalued with an estimated fair value of €233.94, suggesting strong potential based on cash flows. The company recently announced a significant investment of €120 million in automated production facilities to bolster its market position in sports and health sectors, aiming for substantial sales growth. Despite high share price volatility, AlzChem's earnings are projected to grow 19.8% annually, outpacing the German market's average growth rate.

XTRA:ACT Discounted Cash Flow as at Jan 2026
XTRA:ACT Discounted Cash Flow as at Jan 2026

Make It Happen

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.